| http://www.w3.org/ns/prov#value | - The project being advanced by ARMGO Pharma is focused on a novel class of small molecule drugs known as Rycals?? which target the Ryanodine Receptor (RyR), an intracellular calcium channel that becomes leaky in disease states, including Kennedy's Disease, and contributes to loss of muscle strength and function.Kennedy's Disease (KD) is a rare and currently incurable and non-treatable recessive X-l
|
